## Bharat Immunologicals Probability Of Bankruptcy |

Bharat Immunologicals Biologicals Corp Ltd -- India Stock | ## INR 22.00 0.95 4.51% |

Symbol | Refresh |

## Probability Of Bankruptcy Analysis

For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis. The score is used to predict probability of a firm or a fund experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.Bharat Immunologicals |
| = | 15 % |

## About Probability Of Bankruptcy

Probability of Bankruptcy SHOULD NOT be confused with actual chance of a company to file for chapter 7, 11, 12 or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty to meet its current financial obligations towards its creditors or to deliver on the expectations of its investors. Macroaxis derives these conditions on a daily bases from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns including short term and long term historical volatility. Other factors taken into account include analysis of liquidity, revenues patterns, R&D expenses and commitments, as well as public headlines and social sentiment.Compare to competition |

Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Probability Of Bankruptcy of 15.0%. This is much higher than that of the sector, and significantly higher than that of Probability Of Bankruptcy industry, The Probability Of Bankruptcy for all stocks is over 1000% lower than the firm.

## Peer Comparison

Bharat Immunologicals Probability Of Bankruptcy Comparison

Bharat Immunologicals is currently under evaluation in probability of bankruptcy category among related companies.

## Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets |

Hide View All Next | Launch Price Transformation |

## Fundamental Indicators

Current Bharat Immunologicals financial ratios

Return On Asset | (1.69) % | ||

Profit Margin | (4.18) % | ||

Operating Margin | (5.13) % | ||

Current Valuation | 862.5 M | ||

Shares Outstanding | 43.18 M | ||

Price to Earning | (21.09) times | ||

Price to Book | 2.50 times | ||

Price to Sales | 0.66 times | ||

Revenue | 1.28 B | ||

Gross Profit | 119 M | ||

EBITDA | (56.51 M) | ||

Net Income | (53.46 M) | ||

Cash and Equivalents | 152.27 M | ||

Cash per Share | 3.55 times | ||

Total Debt | 177.56 M | ||

Debt to Equity | 0.50 times | ||

Current Ratio | 1.69 times | ||

Earnings Per Share | (1.24) times | ||

Market Capitalization | 1.13 B | ||

Z Score | 3.6 |